###begin article-title 0
###xml 30 36 <span type="species:ncbi:9986">rabbit</span>
Cloning and expression of the rabbit prostaglandin EP2 receptor
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Prostaglandin E2 (PGE2) has multiple physiologic roles mediated by G protein coupled receptors designated E-prostanoid, or "EP" receptors. Evidence supports an important role for the EP2 receptor in regulating fertility, vascular tone and renal function.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 231 232 231 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 253 254 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 259 260 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 323 324 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 329 330 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 334 340 332 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 363 364 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 369 370 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 637 638 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 891 898 885 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 925 926 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 16 22 <span type="species:ncbi:9986">rabbit</span>
###xml 176 182 <span type="species:ncbi:9986">rabbit</span>
###xml 628 634 <span type="species:ncbi:9986">rabbit</span>
The full-length rabbit EP2 receptor cDNA was cloned. The encoded polypeptide contains 361 amino acid residues with seven hydrophobic domains. COS-1 cells expressing the cloned rabbit EP2 exhibited specific [3H]PGE2 binding with a Kd of 19.1+/- 1.7 nM. [3H]PGE2 was displaced by unlabeled ligands in the following order: PGE2>>PGD2=PGF2alpha=iloprost. Binding of [3H]PGE2 was also displaced by EP receptor subtype selective agonists with a rank order of affinity consistent with the EP2 receptor (butaprost>AH13205>misoprostol>sulprostone). Butaprost free acid produced a concentration-dependent increase in cAMP accumulation in rabbit EP2 transfected COS-1 cells with a half-maximal effective concentration of 480 nM. RNase protection assay revealed high expression in the ileum, spleen, and liver with lower expression in the kidney, lung, heart, uterus, adrenal gland and skeletal muscle. In situ hybridization localized EP2 mRNA to the uterine endometrium, but showed no distinct localization in the kidney. EP2 mRNA expression along the nephron was determined by RT-PCR and its expression was present in glomeruli, MCD, tDL and CCD. In cultured cells EP2 receptor was not detected in collecting ducts but was detected in renal interstitial cells and vascular smooth muscle cells. EP2 mRNA was also detected in arteries, veins, and preglomerular vessels of the kidney.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
EP2 expression pattern is consistent with the known functional roles for cAMP coupled PGE2 effects in reproductive and vascular tissues and renal interstitial cells. It remains uncertain whether it is also expressed in renal tubules.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 285 286 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 345 346 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 416 417 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 424 425 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 496 497 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 595 596 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 602 603 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 631 633 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 668 669 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 676 677 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 827 828 827 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 953 954 953 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 964 965 964 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1020 1021 1020 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1282 1283 1282 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1337 1338 1337 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
Prostaglandin E2 is a major cyclooxygenase metabolite of arachidonic acid which exerts diverse effects on vascular smooth muscle tone and epithelial solute transport via G-protein coupled receptors [1,2]. At least four distinct G-protein coupled PGE2 receptors have been cloned: the EP1, EP2, EP3, and EP4[1]. Pharmacological studies suggest PGE2 relaxes vascular smooth muscle through two of these receptors, the EP2 and EP4 receptors, which couple to cyclic-AMP generation [3]. In contrast, PGE2 constricts other vascular smooth muscle through EP3 receptors which inhibit cAMP generation via Gi or EP1 receptors which increase Ca2+ mobilization [3]. Although both EP2 and EP4 receptors relax smooth muscle, EP2 receptors are uniquely sensitive to the agonists butaprost and AH13205 [3,4]. Previous studies have shown that PGE2 increases the cAMP concentration in many tissues including kidney, intestine and uterus, but the relative contribution of EP2 versus EP4 receptors to these effects is incompletely defined [5,6]. Recent studies in mice with targeted disruption of these receptors have suggested an important role for EP2 receptor in regulating systemic hemodynamics. Deficiency of the EP2 receptor is associated with a defect in counteracting vasopressor effect of PGE2 [7] and the development of salt sensitive hypertension [8], suggesting a predominant normal vasodepressor role of EP2 receptor in blood pressure regulation.
###end p 8
###begin p 9
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">++</sup>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The vasodepressor action of PGE2 may also play an important role in the kidney. It has been previously shown that PGE2 not only directly dilates renal arteries [9-11] but also attenuates the AngII-induced increase in renal vascular resistance [12] through inhibition of AngII-elicited intracellular Ca++ increase in vascular smooth muscle cells of preglomerular vasculature [13]. Based on the fact that PGE2 stimulates cAMP generation in freshly isolated preglomerular renal arterioles [14], the cAMP-stimulating EP2 or EP4 receptor has been thought to mediate these effects of PGE2 on renal resistance vessels.
###end p 9
###begin p 10
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 466 467 466 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 457 463 <span type="species:ncbi:9986">rabbit</span>
###xml 649 655 <span type="species:ncbi:9986">rabbit</span>
There is also evidence suggesting that intrarenal EP2 and EP4 receptor activates cAMP-stimulated salt and water transport along the nephron [15-18]. Although the localization of EP1, EP3 and EP4 has been determined in human kidney by in situ hybridization, segmental distribution of cAMP-coupled EP2 receptor along the nephron was not detected by this method [19]. To more clearly define the physiologic role of this cAMP coupled EP receptor, we cloned the rabbit EP2 receptor, characterized its pharmacology and signaling. These studies also defined the tissue distribution with a focus on vascular, intrarenal and reproductive localization of the rabbit EP2 receptor mRNA.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Receptor isolation
###end title 12
###begin p 13
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 36 42 <span type="species:ncbi:9986">rabbit</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 612 617 <span type="species:ncbi:9606">human</span>
Screening of 5 x 105 plaques from a rabbit genomic library using a full-length human cDNA for the EP2 receptor resulted in isolation of two independent clones designated 4B1 (13 kb) and 6A (11 kb). A 5' coding exon of EP2 receptor was contained in clone 4B1, while a 3' coding exon was contained in clone 6A. Sequence data indicated that the entire coding region was present in these two exons. A potential translation initiation codon in the NotI/BamHI fragment (3 kb) of clone 4B1 starts an open reading frame that encodes a polypeptide sequence highly homologous to the first six transmembrane domains of the human EP2 receptor [20]. The amino acid sequence of the open reading frame in the NotI fragment (6 kb) of clone 6A was homologous to the seventh transmembrane domain (TMD VII), followed by a short C-terminal tail and an in-frame stop codon. An intron with a donor and acceptor splice site was located following the coding region corresponding to the sixth transmembrane domain of the protein.
###end p 13
###begin p 14
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 512 513 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 52 58 <span type="species:ncbi:9986">rabbit</span>
###xml 726 732 <span type="species:ncbi:9986">rabbit</span>
A functional cDNA clone was obtained by screening a rabbit uterus cDNA library using a 700 bp AvaII cDNA fragment from clone 4B1. Two types of positive overlapping clones (18A and REP2-2.7) were isolated. Of the 18 positive cDNA clones isolated, 8 belonged to the type designated REP2-18A, and 10 clones belonged to the type designated REP2-2.7. Sequence analysis indicated that these two cDNAs possess an identical open reading frame and 1,664 bp of down-stream 3' untranslated region (3'UTR), however clone REP2-18A possesses an 467 additional base pairs in the 3'UTR compared with REP2-2.7. It is also noted that there are 6 and 7 AUUUA motifs in 3' UTR of REP2-2.7 and REP2-18A, respectively, suggesting an instability of rabbit EP2 receptor mRNA in vivo.
###end p 14
###begin p 15
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 221 222 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 932 933 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 957 958 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1015 1016 1015 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 13 19 <span type="species:ncbi:9986">rabbit</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 157 163 <span type="species:ncbi:9986">rabbit</span>
###xml 212 218 <span type="species:ncbi:9986">rabbit</span>
###xml 392 398 <span type="species:ncbi:9986">rabbit</span>
###xml 600 606 <span type="species:ncbi:9986">rabbit</span>
###xml 923 929 <span type="species:ncbi:9986">rabbit</span>
###xml 939 944 <span type="species:ncbi:9606">human</span>
###xml 949 954 <span type="species:ncbi:10090">mouse</span>
Because both rabbit EP2 cDNA clones, 18A and REP2-2.7, lacked ~50 codons corresponding to the 5' end of the human EP2 receptor and which were present in the rabbit genomic sequence, a full-length sequence of the rabbit EP2 was constructed by ligating a SacII/XhoI cDNA fragment (nucleotide 340-1655) from the cDNA clone 18A with the upstream Hind III/SacII fragment (nucleotide 1-340) of the rabbit genomic clone. This created an open reading frame of 1,083 base pairs with an in-frame TGA stop codon. The existence of this 5' UTR sequence in native cDNA was confirmed by RT-PCR on RNA isolated from rabbit uterus (data not shown). The predicted polypeptide is comprised of 361 amino acids with a calculated molecular weight of ~40 kDa. Its hydrophobic profile reveals the presence of seven hydrophobic stretches characteristic of G-protein-coupled receptors [20] (Fig. 1). Comparison of the deduced amino acid sequence of rabbit EP2 with human and mouse EP2 shows 90% and 82% sequence identity, respectively (Fig. 1).
###end p 15
###begin p 16
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 48 54 <span type="species:ncbi:9986">rabbit</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Alignment of the deduced amino acid sequence of rabbit EP2 (rabEP2) with human (hEP2) and mouse EP2 (mEP2). Underlined sequences denote transmembrane domains. Sequences were deduced from cDNA sequences and aligned using CLUSTALV program. (*) = identical sequence; (.) = conserved sequence. (-)= gaps in sequence alignment. (GenBank accession number (pending).
###end p 16
###begin title 17
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Ligand binding properties of the EP2 receptor
###end title 17
###begin p 18
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 256 257 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 348 351 346 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 627 628 625 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 646 647 644 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 653 659 651 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 666 668 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 672 673 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 678 679 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 721 726 715 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2/3/4</sub>
###xml 778 781 772 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/3</sub>
###xml 808 810 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 832 833 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 899 900 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 905 906 899 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 921 922 915 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1009 1010 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1021 1023 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1024 1026 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 13 19 <span type="species:ncbi:9986">rabbit</span>
###xml 133 139 <span type="species:ncbi:9986">rabbit</span>
###xml 1000 1006 <span type="species:ncbi:9986">rabbit</span>
The putative rabbit EP2 receptor was pharmacologically characterized using membranes from COS-1 cells transiently transfected with a rabbit EP2 expression vector, pcDNA3/REP2. Membranes from EP2 receptor transfected COS-1 cells, exhibited saturable [3H]PGE2 binding with a dissociation constant of 19.1 +/- 1.7 nM, and a maximum binding capacity (Bmax) of 2.8 pmol/mg of membrane protein. Radioligand binding studies were performed using various prostanoids and EP-receptor subtype-specific agonists to compete for PGE2 binding. Competition binding experiments revealed a rank order affinity consistent with an EP receptor: PGE2 >> iloprost = PGD2 = PGF2alpha (Fig. 2A). [3H]PGE2 binding was partially displaced by the EP2/3/4 agonist misoprostol and was not displaced by the EP1/3 agonist sulprostone (Fig. 2B). Furthermore, the EP2 selective agonists butaprost free acid and AH13205 competed for [3H]PGE2 binding with Ki values of 3-7 muM and 3-4 muM, respectively, suggesting this receptor is the rabbit EP2 receptor [20,21].
###end p 18
###begin p 19
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 300 301 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 308 310 308 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Competition binding profile of the EP2 receptor expressed in COS-1 cells. Membranes were incubated with 1.5-2 nM [3H]PGE2 and varying concentrations of competitors. The data shown are from a single experiment performed in triplicate and are representative of three to four experiments. Panel A: ■ PGE2; ▼ PGF2a; ▲ PGD2; ◆ iloprost. Panel B: square butaprost free acid; ?? AH13205; big dn tri, open misoprostol; ◇ sulprostone.
###end p 19
###begin title 20
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Signal transduction properties of the EP2 receptor
###end title 20
###begin p 21
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 141 143 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Incubation of EP2-transfected COS1 cells with butaprost free acid produced a concentration-dependent increase in cAMP accumulation with an EC50 of 480 nM (Fig. 3). Cells transfected with the vector alone demonstrated no significant increase in cAMP in response to butaprost free acid.
###end p 21
###begin p 22
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 443 444 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 110 116 <span type="species:ncbi:9986">rabbit</span>
###xml 434 440 <span type="species:ncbi:9986">rabbit</span>
Butaprost free acid mediated stimulation of intracellular cAMP production in COS-1 cells transfected with the rabbit EP2 receptor. Cells were incubated with various concentrations of PGE2 in the presence of IBMX for 5 minutes. The reactions were stopped with 10% TCA, and cell lysates were analyzed for cAMP content by a cAMP EIA kit. The data shown are from a single experiment and are representative of 3 independent experiments. ▲ rabbit EP2 transfected; ■ vector only transfected.
###end p 22
###begin title 23
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 27 33 <span type="species:ncbi:9986">rabbit</span>
Tissue distribution of the rabbit EP2 receptor
###end title 23
###begin p 24
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 640 641 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 705 706 705 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 728 729 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 808 814 <span type="species:ncbi:9986">rabbit</span>
Solution hybridization/RNase protection assays with a radiolabeled antisense EP2 riboprobe resulted in a RNase-resistant fragment of the appropriate size (322 bp, Fig. 4). EP2 receptor mRNA was detected in several tissues including ileum, spleen, and liver. Lower expression was found in kidney, uterus, lung, heart, liver, adrenal gland, brain, urinary bladder and skeletal muscle. Furthermore, EP2 receptor mRNA was detected by RNase protection assay in all blood vessels examined (Fig. 5) including arteries and veins of large and small caliber (Fig. 5A &5C), and renal preglomerular vasculature (Fig. 5B). The expression level of the EP2 receptor mRNA in these vessels was comparable to that of the EP4 receptor (Fig. 5). EP2 receptor mRNA was also detected in vascular smooth muscle cells cultured from rabbit aorta (Fig. 6A).
###end p 24
###begin p 25
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 86 92 <span type="species:ncbi:9986">rabbit</span>
RNase protection assay demonstrating the distribution of EP2 and GAPDH mRNA in normal rabbit tissues. The protected fragments were electrophoretically separated on a 6% agarose/7 M urea gel. The film was exposed for 36 hours. A 100 bp ladder was used as a size marker. Densitometry was used to quantitate EP2 mRNA expression, RNA loading was corrected by normalizing to GAPDH mRNA expression.
###end p 25
###begin p 26
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 316 317 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 357 358 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 434 435 434 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 94 100 <span type="species:ncbi:9986">rabbit</span>
###xml 332 338 <span type="species:ncbi:9986">rabbit</span>
###xml 454 460 <span type="species:ncbi:9986">rabbit</span>
RNase protection assay demonstrating the distribution of EP1, EP2, EP3, EP4 and GAPDH mRNA in rabbit vascular tissues. The protected fragments were electrophoretically separated on a 6% agarose/7 M urea gel. The film was exposed for 36 hours. A 100 bp ladder was used as a size marker. Panel A: EP1, EP2, EP3, and EP4 expression in rabbit aorta. Panel B: EP2 and EP4 expression in preglomerular microvessels in the kidney. Panel C: EP2 expression in the rabbit ear artery, jugular vein and vena cava.
###end p 26
###begin p 27
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 119 125 <span type="species:ncbi:9986">rabbit</span>
RNase protection assay demonstrating EP2 and EP4 expression in cultured vascular smooth muscle cells isolated from the rabbit aorta (Panel A), cultured cortical collecting duct cells (CCD) (Panel B) and cultured glomerular mesangial cells (MCs) and medullary interstitial cells (MICs) (Panel C). To determine the regulation of EP2 expression in MCs and MICs, cells were treated with 1 muM phorbol 12-myristate 13-acetate (PMA) for 6 hours and EP2 mRNA level was examined by Nuclease protection assay (Panel C).
###end p 27
###begin title 28
###xml 31 37 <span type="species:ncbi:9986">rabbit</span>
Intrarenal localization of the rabbit EP2 receptor
###end title 28
###begin p 29
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 197 199 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1088 1089 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1296 1297 1295 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 138 144 <span type="species:ncbi:9986">rabbit</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
###xml 415 421 <span type="species:ncbi:9986">rabbit</span>
###xml 514 517 <span type="species:ncbi:9606">man</span>
###xml 580 586 <span type="species:ncbi:9986">rabbit</span>
###xml 1066 1072 <span type="species:ncbi:9986">rabbit</span>
In situ hybridization was performed to examine the distribution of the EP2 receptor gene expression in the kidney and uterus. Sections of rabbit renal and uterine tissues were hybridized with the [35S]-labeled riboprobe from the same cDNA probe used in RNase-protection assays. As observed for the mouse EP2 in the uterus, a significant hybridization signal was detected mainly in the endometrial epithelium of the rabbit uterus with less expression in myometrium (Fig. 7). Consistent with previous observation in man [19], only a diffuse weak EP2 mRNA signal was detected in the rabbit kidney (Figure 7). To further elucidate the distribution of EP2 receptor along the nephron, nephron segments were dissected and expression of EP2 was determined using RT-PCR. As shown in figure 8, PCR products with expected sizes were obtained for both EP2 receptor (336 bp) and GAPDH (411 bp). Identity of the amplified products was confirmed by Southern hybridization (not shown) and sequencing. As positive control, RT-PCR was performed using 1 mug of total RNA isolated from rabbit spleen (figure 8). As negative control, PCR were also performed in the absence of reverse transcription without identifiable product, indicating the origination of PCR products were from mRNA other than genomic DNA (figure 8). EP2 receptor mRNA was easily detected in glomeruli and medullary collecting ducts (MCD). Detectable EP2 mRNA was also present in thin descending limbs of Henle (tDL) and cortical collecting ducts (CCD).
###end p 29
###begin p 30
###xml 410 411 410 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 25 31 <span type="species:ncbi:9986">rabbit</span>
###xml 64 70 <span type="species:ncbi:9986">rabbit</span>
###xml 401 407 <span type="species:ncbi:9986">rabbit</span>
In situ hybridization of rabbit EP2 showing mRNAdistribution in rabbit kidney (A) and uterus (B). A: autoradiographydemonstrating low and ubiquitous expression of EP2 mRNA expression inrabbit kidney. Dark black areas indicate regions of hybridization with the antisense riboprobe (right panel). In contrast, no hybridization was seen using a sense probe (left panel). B: In situ hybridization showing rabbit EP2 mRNA signals in the uterus. Autoradiography (left panels) and photomicrograph (right panel, 400 Xdarkfield, white grains) showing specific hybridization of the antisense probe to uterus endometrium.
###end p 30
###begin p 31
###xml 163 169 <span type="species:ncbi:9986">rabbit</span>
RT-PCR analysis demonstrating distribution of EP2 receptor (right upper panel) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (right lower panel) mRNA along rabbit nephron. PCR products were electrophoretically separated on a 1% agarose gel. RNA loading was corrected by normalizing to GAPDH mRNA expression. Data are from a single experiment and represent three independent experiments. Left panels showing positive and negative control for EP2 (upper) and GAPDH (lower). Note: PCT, proximal convoluted tubules; PST, proximal straight tubules; tDL, the thin descending limb of Henle; TAL, thick ascending limb; DCT, distal convoluted tubules; CCD and MCD, cortical and medullary collecting ducts.
###end p 31
###begin p 32
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 262 268 <span type="species:ncbi:9986">rabbit</span>
In cultured cells RNase protection assay detected EP2 expression in renal medullary interstitial cells (MICs), while no signal was detected in cultured cortical collecting ducts or glomerular mesangial cells (Fig. 6B &6C). EP2 mRNA was also detected in cultured rabbit aortic vascular smooth muscle cells (Figure 6A).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 277 278 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 552 553 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 680 681 680 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 960 961 960 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1006 1007 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1049 1051 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1072 1073 1072 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1196 1197 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1416 1417 1416 1417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1431 1433 1431 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 69 75 <span type="species:ncbi:9986">rabbit</span>
###xml 140 146 <span type="species:ncbi:9986">rabbit</span>
###xml 219 225 <span type="species:ncbi:9986">rabbit</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 268 274 <span type="species:ncbi:9986">rabbit</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
###xml 526 531 <span type="species:ncbi:10090">mouse</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 671 677 <span type="species:ncbi:9986">rabbit</span>
###xml 1087 1092 <span type="species:ncbi:10090">mouse</span>
###xml 1187 1193 <span type="species:ncbi:9986">rabbit</span>
The present studies describe the cloning and characterization of the rabbit EP2 receptor. With this information, cDNA sequence for all four rabbit EP receptors is now available [22-24]. Several similarities between the rabbit and mouse EP2 receptors exist [5,21]. The rabbit EP2 genomic clone contains an intron with consensus splice donor and acceptor sites near the end of transmembrane domain (TM) VI. The relative position of the intron to the coding regions is also identical to that found in the human TP, the human and mouse DP, and the human EP1 gene [2]. This provides further evidence that the prostanoid receptor family arose from a common ancestral gene. The rabbit EP2 gene contains a 1,083 bp open reading frame coding for a 361 amino acid polypeptide, with a calculated molecular weight of 39,919 Daltons. Its amino acid profile reveals the presence of seven hydrophobic regions which likely represent transmembrane domains. Unlike the TP and EP3 receptors, no alternative splicing in the EP2 receptor was found in the coding region [21,25]. Diversity of EP2 mRNAs in the mouse was found in both the 5' UTR and the 3' UTR [21]. Similar diversity in the 3' sequence of the rabbit EP2 receptor cDNA clones isolated from the uterine library was observed in the present studies. The significance of this mRNA splicing is not yet known, but it might play a role in stability or translation efficiency of EP2 transcripts [21].
###end p 34
###begin p 35
###xml 84 85 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 186 192 186 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 255 256 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 260 261 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 278 279 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 280 281 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 310 311 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 339 340 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 341 343 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 344 346 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 436 437 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 493 494 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 500 501 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 565 566 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 591 592 587 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 662 663 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 726 727 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 855 856 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 957 958 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 959 961 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 962 964 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1114 1115 1110 1111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1142 1143 1138 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 40 46 <span type="species:ncbi:9986">rabbit</span>
###xml 531 537 <span type="species:ncbi:9986">rabbit</span>
###xml 582 588 <span type="species:ncbi:9986">rabbit</span>
###xml 653 659 <span type="species:ncbi:9986">rabbit</span>
###xml 846 852 <span type="species:ncbi:9986">rabbit</span>
###xml 921 926 <span type="species:ncbi:9606">human</span>
###xml 928 931 <span type="species:ncbi:10116">rat</span>
###xml 936 941 <span type="species:ncbi:10090">mouse</span>
Ligand binding studies confirm that the rabbit EP2 receptor preferentially binds PGE2 with significantly higher affinity than other endogenous prostanoids. Its low affinity for PGD2, PGF2alpha, iloprost, misoprostol and sulprostone suggest it is not an EP1, EP3 or IP receptor [2,3]. As demonstrated for the EP2 receptor in other species [6,20,21], butaprost free acid and AH 13205, two synthetic PG agonists with selectivity for the EP2 subtype, efficiently and dose dependently compete for [3H] PGE2 binding to this newly cloned rabbit receptor. Inhibition of PGE2 binding to the rabbit EP2 receptor by AH13205 is about 100 times greater than that to rabbit EP4 in transfected COS-1 cells (unpublished data). Finally, the EP2 selective agonist butaprost free acid dose-dependently stimulated cAMP generation in COS-1 cells transfected with the rabbit EP2 receptor. These results are in agreement with observations with human, rat and mouse EP2 receptors [6,20,21], which also couple to cAMP generation. Taken together, these results clearly demonstrate that the pharmacology of this receptor corresponds to an EP2 receptor rather than an EP4 receptor.
###end p 35
###begin p 36
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 345 346 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 664 665 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 24 30 <span type="species:ncbi:9986">rabbit</span>
###xml 110 116 <span type="species:ncbi:9986">rabbit</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
The expression level of rabbit EP2 receptor mRNA is relatively low. Nuclease protection analysis demonstrated rabbit EP2 expression is highest in ileum, liver, and spleen, with a lower expression in kidney, uterus, brain, adrenal gland, lung, heart, bladder, stomach and skeletal muscle. This mRNA expression pattern is similar to that of the EP2 in the mouse [5,21]. PGE2 has been reported to stimulate cAMP formation in many tissues, including intestine, microdissected renal tubule segments, and uterus via butaprost sensitive and insensitive receptors [14,26-29]. The mRNA expression results are consistent with these functional studies and suggest that the EP2 receptor plays important roles in mediating PGE2 stimulated cAMP generation in these tissues [14,21,26-33].
###end p 36
###begin p 37
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 462 463 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 585 586 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 628 629 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 822 823 822 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 892 893 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 893 896 893 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 20 26 <span type="species:ncbi:9986">rabbit</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
The presence of the rabbit EP2 receptor mRNA in the uterus also support a role for this receptor as an important mediator of PGE2 action in this organ. This is in agreement with previous studies which demonstrate that EP2 is expressed and highly regulated in uterine luminal epithelium cells by ovarian steroids during the peri-implantation period [5,21,34,35]. The change in level of the EP2 receptor expression in the uterus may contribute to the increase in GS protein content and cAMP concentration in mid-gestation and the decrease at term [26,27]. Because the EP2 receptor is a GS-coupled cAMP-stimulating receptor, the EP2 receptor may participate in the physiological regulation of uterine relaxation during pregnancy and the transition into uterine contraction at the onset of the labor. Lack of normal uterine EP2 expression may also contribute to implantation defect reported in EP2-/- mice [8,36].
###end p 37
###begin p 38
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 451 452 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 566 567 566 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 688 689 688 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 773 774 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 803 804 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 911 912 911 912 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 296 302 <span type="species:ncbi:9986">rabbit</span>
###xml 402 408 <span type="species:ncbi:9986">rabbit</span>
###xml 609 615 <span type="species:ncbi:9986">rabbit</span>
PGE2 also plays a critical role in regulating systemic blood pressure [37,38]. Although the receptor mediating the predominant vasodilator effect of PGE2 remains only partially defined, recent gene targeting studies suggest that the EP2 receptor may be an important vasodilator in vivo[7,8]. The rabbit ear artery has been used as a classic pharmacological model of an EP2 responsive tissue, while the rabbit jugular vein has been proposed to be an EP4 bearing target tissue [3,4,39], however in the present studies EP2 receptor mRNA was detected in both vessels. EP2 mRNA expression was also detected in the rabbit aorta and inferior vena cava thus providing further evidence that the EP2 receptor is functionally expressed in both arteries and veins. Expression of this GS-coupled cAMP-stimulating PGE2 receptor in cultured vascular smooth muscle cells isolated from the aorta supports a direct role of the EP2 receptor in mediating vascular relaxation.
###end p 38
###begin p 39
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 407 408 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 472 479 472 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 529 530 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1693 1694 1693 1694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1723 1724 1723 1724 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1820 1822 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1823 1825 1823 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 455 461 <span type="species:ncbi:9986">rabbit</span>
PGE2 has also been shown to stimulate cAMP formation in several renal tissues, notably preglomerular microvasculature [14], renal glomeruli [40], thin descending limb [41], medullary and cortical thick ascending limb, and collecting duct [29,42]. Although EP2 receptor mRNA expression was detected in the kidney and this was more pronounced in the renal cortex than in the medulla, no specific regions of EP2 receptor mRNA expression could be detected in rabbit kidney by in situ hybridization [19]. Nonetheless, low levels of EP2 receptor mRNA expression were detected by RT-PCR or RNase protection assay in nephron segments within the kidney including preglomerular vasculature, glomeruli, thin limbs of Henle's loop and collecting ducts. The expression of EP2 receptor mRNA in medullary collecting duct is distinct from functional studies in the cortical collecting duct where butaprost had no functional effect [17,18]. These data suggest a possible unique role for the EP2 receptor in the medullary collecting duct as opposed to cortical collecting duct. Alternatively the PCR detection of EP2 receptor expression in these microdissected segments might result from the adherent renal interstitial cells other than collecting duct itself, since nuclease protection analysis revealed a relatively high EP2 level in cultured intersitial cells but failed to detect EP2 expression in cultured collecting duct cells. It is notable that glomeruli and collecting ducts are distinguished from other segments by high number of adherent cells. Selective expression of the EP2 receptor in interstitial cells is consistent with a lack of segmental localization by in situ hybridization. Whether the EP2 receptor participates in PGE2 stimulated cAMP generation in epithelial cells along the nephron awaits further investigation [14,42].
###end p 39
###begin title 40
Conclusions
###end title 40
###begin p 41
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 198 199 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 63 69 <span type="species:ncbi:9986">rabbit</span>
###xml 138 144 <span type="species:ncbi:9986">rabbit</span>
In summary, we have cloned and expressed a butaprost sensitive rabbit PGE2 receptor that stimulates cAMP formation and is present in many rabbit tissues. Physiological effects of PGE2 through the EP2 receptor may mediate important physiological actions in these tissues. EP2 expression in uterus, vasculature and the kidney suggests that this receptor may play important roles in the functions of reproductive system, vascular tissues and interstitium of the kidney.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Ligands
###end title 43
###begin p 44
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 19 20 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 29 35 29 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2&#945;</sub>
###xml 411 412 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 418 419 414 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Unlabeled PGE2, PGD2, and PGF2alpha were purchased from Cayman Chemical (Ann Arbor). Butaprost free acid was a gift from Dr. Jilly Evans, Merck-Frosst. Sulprostone, misoprostol, iloprost and AH13205 were kindly provided by Dr. Harold Kluender of Miles Laboratories, P.J. Gardiner of Bayer UK, Dr. Paul Collins of G.D. Searle, Dr. Rubanie of Berlex Laboratories and Dr. R.A. Coleman of Glaxo, UK, respectively. [3H] PGE2 was purchased from Dupont NEN.
###end p 44
###begin title 45
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
Rabbit genomic library screening
###end title 45
###begin p 46
###xml 38 41 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 84 86 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 117 118 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 174 176 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 404 405 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 500 501 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 2 8 <span type="species:ncbi:9986">rabbit</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
A rabbit genomic library in Lamda DASH(R) II vector (Stratagene) was screened with [32P]-labeled full-length human EP2 (gift from Dr. D. Woodward, Allergan Pharmaceuticals) [20]. The filters were fixed by ultraviolet light exposure (Stratalinker, Stratagene) and hybridized 18 hours at 56degreesC in a solution containing 6X SSC, 5X Denhardt's, 0.1% SDS, 150 mug/ml denatured herring sperm DNA and 3 x 106 cpm/ml labeled probe. Two representative positive clones, 4B and 6A, were isolated from 5 x 105 recombinant plaques and shown to exhibit unique restriction patterns. A XbaI/NotI fragment from clone 4B1 and a NotI fragment from 6A1 hybridized to the probe and were subcloned in pBluesript II SK(-) (Stratagene) for further analysis.
###end p 46
###begin title 47
cDNA cloning
###end title 47
###begin p 48
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 2 8 <span type="species:ncbi:9986">rabbit</span>
A rabbit uterus cDNA library in ZAP II (Stratagene) (a gift from Dr. J. Lytton, Harvard Medical School) was screened using an AvaII cDNA fragment of 750 bp from the genomic clone 4B1. 106 plaques were probed under high stringency, and 18 positive plaques were purified. The isolated cDNA-bearing phages were rescued to plasmids according to the manufacturer's instruction. Clones were analyzed by restriction digestion, and nucleotide sequencing was carried out on both strands by the dideoxy chain termination method.
###end p 48
###begin title 49
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Construction of an open reading frame of EP2 and its expression in COS-1 cells
###end title 49
###begin p 50
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 892 894 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
One 5' truncated cDNA clone, REP2-18A, was highly homologous to the human EP2 receptor but lacked the 5' 150 bp encoding the first 50 amino acids (see results). REP2-18A was digested by Sac II/Xho I, and the 3' restriction fragment (1,312 bp) was ligated to the Sac II/Hind III fragment (350 bp) of the 4B1 genomic clone at the Sac II site. This resulted in a 1.7 kb fragment, YZ4, containing a putative open reading frame. YZ4 was then subcloned into the eukaryotic expression vector pcDNA3 (Invitrogen) and the resultant plasmid, pcDNA3/REP2, was transfected into COS-1 using lipofectamine according to the manufacturer's directions (Life Science Technologies) with 12 mug plasmid DNA and 45 muL lipofectamine solution. Cells were cultured for 72 hours, and 5 mM sodium butyrate was added to culture medium 16 hours before lysis. Total cell membranes were prepared as described previously [23].
###end p 50
###begin title 51
Ligand binding analysis
###end title 51
###begin p 52
###xml 143 144 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 150 151 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 207 208 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 227 228 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 729 730 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 816 817 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 822 823 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Saturation isotherm ligand binding experiments were performed using 15-20 mug of membrane protein incubated with increasing concentrations of [3H] PGE2 at 30degreesC for 2 hours, in binding buffer (25 mM KPO4, pH6.2, 10 mM MgCl2, and 1 mM EDTA). The reaction was stopped by adding 1 ml of ice-cold binding buffer followed by rapid filtration on Inotech IH-201-A21 glass fiber filters employing an Inotech 96 well filtration manifold (Inotech Biosystems, Lansing, MI). Filters then were washed 3 times with binding buffer, dried briefly and counted in a Beckman LS 6500 multi-purpose scintillation counter. Nonspecific binding was defined as the radioactivity remaining bound to the filter in the presence of 50 muM unlabelled PGE2. For competition binding assays, 20 mug of membrane protein was incubated with 1 nM [3H]PGE2 and varying concentrations of unlabeled competitors. Reactions were carried out as above.
###end p 52
###begin title 53
cAMP measurements
###end title 53
###begin p 54
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
COS1 cells were transiently transfected with the EP2 receptor expression plasmid were distributed onto 24-well plates. The medium was replaced 24 hours later and incubated one additional hour at 37degreesC in 450 muL DMEM plus 0.25 mM 3-isobutyl-1-methylxanthine (IBMX), and 40 mM indomethacin. Following this medium containing varying amounts of butaprost free acid was added to each well for 5 minutes. The reactions were stopped by addition of 500 muL of 10% trichloroacetic acid. cAMP measurement of the cell lysates were performed by an EIA according to manufacturer's instructions (Stratagene).
###end p 54
###begin title 55
Isolation of renal microvessels and dissection of nephron segments
###end title 55
###begin p 56
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1102 1108 <span type="species:ncbi:9986">rabbit</span>
Renal preglomerular microvessels were isolated according to a protocol from Chaudhari and Kirschenbaum [43]. Briefly, in anesthetized animals kidneys were exposed and the renal artery cannulated. The kidneys were perfused with 10 ml of ice cold normal saline, followed by 10 ml of a 1% suspension of magnetized iron oxide (Fe3O4, Aldrich) in normal saline. The cortex of the kidneys was minced with a tissue press and homogenized using a Polytron homogenizer at moderate speed for 15 s x2. Microvessels were separated from nonvascular tissue in several washing steps (in 1x PBS) utilizing a strong magnet field. Washing and separation were repeated after passing the homogenate through 20-, 21- and 23-gauge needles, respectively, until the suspension was mostly free of glomeruli and other nonvascular tissue. This technique provided a large quantity of relatively pure preglomerular microvessels, with approximately 10-15 % of the suspension consisting of attached glomeruli and early segments of proximal tubules. Microdissection of nephron segments was performed in the kidney of New Zealand White rabbit as previously described [44]. The following segments were dissected: glomeruli, proximal convoluted tubules (PCT), proximal straight tubules (PST), thin limbs of Henle's loop (tDL/tAL), thick ascending limb (TAL), distal convoluted tubules (DCT), cortical collecting ducts (CCD) and medullary collecting duct (MCD) cells.
###end p 56
###begin title 57
###xml 20 26 <span type="species:ncbi:9986">Rabbit</span>
PCR ampification of Rabbit EP2 receptor Fragment
###end title 57
###begin p 58
###xml 863 864 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 155 184 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 431 437 <span type="species:ncbi:9986">rabbit</span>
###xml 458 464 <span type="species:ncbi:9986">rabbit</span>
###xml 571 577 <span type="species:ncbi:9986">rabbit</span>
Total RNA was purified from dissected nephron segments using Tri Reagent (Molecular Research Center) and reverse-transcribed to single-stranded cDNA using Moloney murine leukemia virus reverse transcriptase and 2.5 muM of random hexamers according to the manufacturer's protocol (GeneAmp RNA PCR kit, Perkin Elmer Cetus, Norwalk, CT). The cDNAs were then amplified using EP2 and GAPDH selective primers. Primers were selected from rabbit cDNA sequences. For rabbit EP2: 5'-TCC TCC CGA AAA GAA AAG TGG-3' for sense and 5'-TGT TTA CCC CGT TTT ATC AGG-3' for antisense; for rabbit GAPDH: 5'-CGG AGC CAA AAG GGT CAT CAT-3' for sense and 5'-TTT CTC CAG GCG GCA GGT CAG-3' for antisense. These primers were used to amplify a 336 bp of EP2 cDNA fragment and 411 bp of GAPDH cDNA fragment. PCR reactions were carried out in 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2, 0.2 mM dNTPs and 1 muM primers at 94degreesC for 0.5 min, 60degreesC for 0.5 min, and 72degreesC for 1.0 min for 35 cycles in a Perkin Elmer Cetus 9600 thermal cycler. PCR products were separated by 1% agarose gel and further confirmed by Southern hybridization and sequencing.
###end p 58
###begin title 59
###xml 11 17 <span type="species:ncbi:9986">rabbit</span>
Culture of rabbit aortic smooth muscle cells (VSMCs), cortical collecting duct cells (CCD), glomerular mesangial cells (MCs) and renal medullary interstitial cells (MICs)
###end title 59
###begin p 60
###xml 521 523 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 602 604 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 605 607 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 608 610 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 109 115 <span type="species:ncbi:3635">cotton</span>
The aorta was cut open in a longitudinal section and the thin layer of endothelial cells was removed using a cotton-tipped applicator. The aorta was cut into small pieces and suspended in DMEM medium containing 20 % FCS and grown in a culture dish in standard incubation at 37degreesC. One week later, the VSMCs had outgrown from the tissue suspension, and were transferred to a new flask. The medium was changed every other day, the identity of the VSMCs was confirmed by alpha-actin fluorescence staining as described [45]. Glomerular MCs, CCD cells and MICs were cultured as we previously reported [22,44,46].
###end p 60
###begin title 61
Solution hybridization/RNase protection assays
###end title 61
###begin p 62
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 286 287 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 450 451 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 455 456 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 468 469 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 961 963 937 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1307 1308 1277 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 96 102 <span type="species:ncbi:9986">rabbit</span>
###xml 245 251 <span type="species:ncbi:9986">rabbit</span>
###xml 1179 1185 <span type="species:ncbi:9986">rabbit</span>
RNase protection assays were performed as described previously [22]. A Hind III fragment of the rabbit EP2 receptor located in the the 3' untranslated region (3'UTR) was subcloned into pBluescript SK(-) plasmid (Stratagene). Plasmids containing rabbit EP1 (250 bp) [22] EP2 (322 bp), EP3 (466 bp) [24] and EP4 (328 bp) [23] were used to synthesize cRNA probes for solution hybridization of total RNA from various tissues. Briefly, the fragments of EP1, EP2, EP3 and EP4 cDNA were subcloned in pBluscript SK(-) vector, and the antisense orientation was determined by dideoxy-DNA sequencing. Radiolabeled riboprobes were synthesized from linearized plasmid DNA (1 mug) transcribed in vitro with 10 U of T3 RNA polymerase by using MAXIscripttrade mark kit (Ambion) for 1 hour at 37degreesC in a total reaction volume of 20 mul. The reaction buffer contained 10 mM dithiothreitol (DTT), 0.5 muM of ATP, CTP, and GTP, 2.5 muM of UTP, and 5 mul of 800 Ci/mmol [alpha-32P] UTP at 10 mCi/ml (Dupont NEN). Hybridization buffer included 80% deionized formamide, 100 mM sodium citrate, pH6.4, 300 mM sodium acetate, pH6.4 and 1 mM EDTA (RPAII, Ambion). Twenty micrograms of total RNAs from rabbit tissues, preglomerular vessels, cultured cells were incubated at 45degreesC overnight in hybridization buffer with 1 x 105 cpm labeled riboprobe. After hybridization, ribonuclease digestion (20 mg/ml) was carried out at 37degreesC for 30 minutes. Precipitated protected fragments were separated on a 4% polyacrylamide gel at 200 V for 3.5 hours. End-labeled 100 bp DNA markers were used as molecular weight standards (Promega). The gel was exposed to Kodak XAR-5 film overnight at -80degreesC, with intensifying screens.
###end p 62
###begin title 63
In situ hybridization
###end title 63
###begin p 64
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 201 203 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 66 72 <span type="species:ncbi:9986">Rabbit</span>
In situ hybridization was performed as previously described [22]. Rabbit uterus and kidney were fixed in 4% paraformaldehyde, and embedded in paraffin. Seven mum sections were cut and hybridized with [35S]-labeled riboprobe used in the RNase protection assays at 55degreesC for 18 hours. Following hybridization, sections were washed at 50degreesC in 50% formamide, 2X SSC, and 100 mM beta-mercaptoethanol for 60 minutes. Sections were treated with RNase A (10 mug/ml) at 37degreesC for 30 minutes, followed by washes in 10 mM Tris, 5 mM EDTA, 500 mM NaCl at 37degreesC; 2X SSC at 50degreesC; and 0.1X SSC at 50degreesC. Slides were dehydrated with ethanol containing 300 mM ammonium acetate. Photomicrographs were taken from slides dipped in emulsion (Ilford K5, Knutsford, Cheshire, England) diluted 1:1 with 2% glycerol and exposed for 7 days at 4degreesC. After developing in Kodak D-19, slides were counterstained with hematoxylin and eosin. Photomicrographs were taken by a Zeiss Axioskop microscope using dark-field optics.
###end p 64
###begin title 65
Data analysis
###end title 65
###begin p 66
All binding assays and cAMP measurements were plotted using PRISM (GraphPad, San Diego, CA).
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
YG carried out the molecular cloning studies, participated in the sequence alignment and drafted the manuscript. BAS carried out the cAMP assays. YZ participated in examining tissue distribution of EP2 receptor. AS participated in preparation of preglomeruli, OS carried out the nephron dissection. LSD did the in situ hybridization. RR participated in dissecting nephron segments. RMB and MDB supervised the design of the study.
###end p 68
###begin title 69
Abbreviations
###end title 69
###begin p 70
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Prostaglandin E2 (PGE2); cortical thick ascending limb (cTAL); thin descending limb of Henle's loop (tDL); cortical and outer medullary collecting ducts (CCD, OMCD); reverse transcription-polymerase chain reaction (RT-PCR)
###end p 70
###begin title 71
Acknowledgments
###end title 71
###begin p 72
###xml 61 66 <span type="species:ncbi:9606">human</span>
We thank Dr. David Woodward and John Regan for providing the human EP2 receptor cDNA. Support for this project was provided by NIH DK-37097 (to MDB) and a Veterans Administration Merit Award (MDB). Support was also provided by NIH grants DK46205, and GM-15431 (RMB). Dr. M. Breyer is the recipient of a VA Clinical Investigator Career Development Award. Support for this project was also provided by an American Heart Association Beginning Grant-in-Aid 0160200B (to YG), NIH DRTC grant P60-DK-20593 (to YG) and an Atorvastatin Research Award from Pfizer Pharmaceutics (to YG).
###end p 72
###begin article-title 73
Regulation of renal function by prostaglandin E receptors.
###end article-title 73
###begin article-title 74
Prostanoid receptors: structures, properties, and functions.
###end article-title 74
###begin article-title 75
VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
###end article-title 75
###begin article-title 76
###xml 54 60 <span type="species:ncbi:9986">rabbit</span>
###xml 108 114 <span type="species:ncbi:9986">rabbit</span>
Pharmacolgical studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
###end article-title 76
###begin article-title 77
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and Northern blot analysis.
###end article-title 77
###begin article-title 78
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.
###end article-title 78
###begin article-title 79
###xml 20 26 <span type="species:ncbi:10090">murine</span>
Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors.
###end article-title 79
###begin article-title 80
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor.
###end article-title 80
###begin article-title 81
###xml 84 87 <span type="species:ncbi:10116">rat</span>
Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
###end article-title 81
###begin article-title 82
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature.
###end article-title 82
###begin article-title 83
###xml 96 100 <span type="species:ncbi:10116">rats</span>
Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats.
###end article-title 83
###begin article-title 84
Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles.
###end article-title 84
###begin article-title 85
Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC.
###end article-title 85
###begin article-title 86
###xml 56 62 <span type="species:ncbi:9986">rabbit</span>
Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature.
###end article-title 86
###begin article-title 87
###xml 65 71 <span type="species:ncbi:9986">rabbit</span>
Luminal prostaglandin E2 modulates sodium and water transport in rabbit cortical collecting ducts.
###end article-title 87
###begin article-title 88
###xml 97 100 <span type="species:ncbi:9615">dog</span>
The effect of inhibition of prostaglandin synthesis on urinary sodium excretion in the conscious dog.
###end article-title 88
###begin article-title 89
###xml 71 77 <span type="species:ncbi:9986">rabbit</span>
Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct.
###end article-title 89
###begin article-title 90
Prostaglandin E receptors and the kidney.
###end article-title 90
###begin article-title 91
###xml 66 71 <span type="species:ncbi:9606">human</span>
Differential localization of prostaglandin E receptor subtypes in human kidney.
###end article-title 91
###begin article-title 92
###xml 19 24 <span type="species:ncbi:9606">human</span>
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
###end article-title 92
###begin article-title 93
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Characterization of the gene for the mouse prostaglandin E receptor subtype EP2: tissue-specific initiation of transcription in the macrophage and the uterus.
###end article-title 93
###begin article-title 94
PGE2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor.
###end article-title 94
###begin article-title 95
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 30 36 <span type="species:ncbi:9986">rabbit</span>
Cloning and Expression of the rabbit prostaglandin EP4 receptor.
###end article-title 95
###begin article-title 96
###xml 54 60 <span type="species:ncbi:9986">Rabbit</span>
Alternative Splicing Generates Multiple isoforms of a Rabbit Prostaglandin E2 receptor.
###end article-title 96
###begin article-title 97
###xml 48 53 <span type="species:ncbi:9606">human</span>
Characterization and chromosomal mapping of the human thromboxane A2 receptor gene.
###end article-title 97
###begin article-title 98
###xml 73 78 <span type="species:ncbi:9606">human</span>
In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium.
###end article-title 98
###begin article-title 99
###xml 53 58 <span type="species:ncbi:9606">human</span>
In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
###end article-title 99
###begin article-title 100
Alkaline secretion by amphibian duodenum. II. Effects of dBcAMP, theophyllin, and prostaglandins.
###end article-title 100
###begin article-title 101
###xml 39 45 <span type="species:ncbi:9986">rabbit</span>
Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins.
###end article-title 101
###begin article-title 102
###xml 92 97 <span type="species:ncbi:9606">human</span>
Cloning, structural characterization, and chromosomal localization of the gene encoding the human prostaglandin E(2) receptor EP2 subtype.
###end article-title 102
###begin article-title 103
Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in ileal smooth muscle cells.
###end article-title 103
###begin article-title 104
Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2.
###end article-title 104
###begin article-title 105
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors.
###end article-title 105
###begin article-title 106
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation.
###end article-title 106
###begin article-title 107
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
Distinct cellular localization of the messenger ribonucleic acid for prostaglandin E receptor subtypes in the mouse uterus during pseudopregnancy.
###end article-title 107
###begin article-title 108
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor [see comments].
###end article-title 108
###begin article-title 109
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor.
###end article-title 109
###begin article-title 110
###xml 75 81 <span type="species:ncbi:9986">rabbit</span>
Identification of prostaglandin E2 as the principle vasodepressor lipid of rabbit renal medulla.
###end article-title 110
###begin article-title 111
###xml 88 94 <span type="species:ncbi:9986">rabbit</span>
Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
###end article-title 111
###begin article-title 112
Regulation of renal cellular cAMP levels by prostaglandins and alpha 2-adrenoceptors: microdissection studies.
###end article-title 112
###begin article-title 113
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Effect of PGE2 on the cell cyclic AMP content in the thin descending limb of henle of the rat.
###end article-title 113
###begin article-title 114
###xml 71 74 <span type="species:ncbi:10116">rat</span>
Distribution of prostaglandin E2-sensitive adenylate cyclase along the rat nephron.
###end article-title 114
###begin article-title 115
###xml 29 35 <span type="species:ncbi:9986">rabbit</span>
A rapid method for isolating rabbit renal microvessels.
###end article-title 115
###begin article-title 116
Regulation of cyclooxygenase expression in the kidney by dietary salt intake.
###end article-title 116
###begin article-title 117
Effects of proteasome and calpain inhibitors on the structural reorganization and proliferation of vascular smooth muscle cells in primary culture.
###end article-title 117
###begin article-title 118
###xml 39 45 <span type="species:ncbi:9986">rabbit</span>
Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells.
###end article-title 118

